{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:00:50Z","timestamp":1791043250200,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Steven Spielberg Pediatric Research Center"},{"name":"NIH\/NICHD","award":["HD36657"],"award-info":[{"award-number":["HD36657"]}]},{"name":"Medical Genetics NIH\/NIGMS","award":["5-T32-GM08243"],"award-info":[{"award-number":["5-T32-GM08243"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medical Genetics"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.ejmg.2012.01.007","type":"journal-article","created":{"date-parts":[[2012,2,3]],"date-time":"2012-02-03T12:49:43Z","timestamp":1328273383000},"page":"349-353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["De novo microdeletion of Xp11.3 exclusively encompassing the monoamine oxidase A and B genes in a male infant with episodic hypotonia: A genomics approach to personalized medicine"],"prefix":"10.1016","volume":"55","author":[{"given":"Ryan E.","family":"O\u2019Leary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean C.","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Hyland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. Jane Tavyev","family":"Asher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"John M.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmg.2012.01.007_bib1","article-title":"Monoamine oxidase: basic and clinical aspects","author":"Yasuhara","year":"1993","journal-title":"VPS, Zeist, Netherland"},{"key":"10.1016\/j.ejmg.2012.01.007_bib2","doi-asserted-by":"crossref","first-page":"10752","DOI":"10.1523\/JNEUROSCI.2037-10.2010","article-title":"Monoamine oxidases regulate telencephalic neural progenitors in late embryonic and early postnatal development","volume":"30","author":"Cheng","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmg.2012.01.007_bib3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.neuro.22.1.197","article-title":"Monoamine oxidase: from genes to behavior","volume":"22","author":"Shih","year":"1999","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.ejmg.2012.01.007_bib4","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1172\/JCI118492","article-title":"Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes","volume":"97","author":"Lenders","year":"1996","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ejmg.2012.01.007_bib5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/ajmg.1320420126","article-title":"Clinical, biochemical, and neuropsychiatric evaluation of a patient with a contiguous gene syndrome due to a microdeletion Xp11.3 including the Norrie disease locus and monoamine oxidase (MAOA and MAOB) genes","volume":"42","author":"Collins","year":"1992","journal-title":"Am. J. Med. Genet."},{"issue":"38","key":"10.1016\/j.ejmg.2012.01.007_bib6","doi-asserted-by":"crossref","first-page":"39645","DOI":"10.1074\/jbc.M405550200","article-title":"A\u00a0spontaneous point mutation produces MAO A\/B knock-out mice with greatly elevated monoamines and anxiety-like behavior","volume":"279","author":"Chen","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmg.2012.01.007_bib7","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1126\/science.7792602","article-title":"Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAO A","volume":"268","author":"Cases","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.ejmg.2012.01.007_bib8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.gde.2007.04.009","article-title":"Use of array CGH in the evaluation of dysmorphology, malformations, developmental delay, and idiopathic mental retardation","volume":"17","author":"Stankiewicz","year":"2007","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.ejmg.2012.01.007_bib9","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/ejhg.2010.41","article-title":"Deletion of MAOA and MAOB in a male patient causes severe developmental delay, intermittent hypotonia and stereotypical hand movements","volume":"18","author":"Whibley","year":"2010","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ejmg.2012.01.007_bib10","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1126\/science.8211186","article-title":"Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A","volume":"262","author":"Brunner","year":"1993","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.ejmg.2012.01.007_bib11","first-page":"1032","article-title":"X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism","volume":"52","author":"Brunner","year":"1993","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejmg.2012.01.007_bib12","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/ajmg.a.31521","article-title":"Contiguous deletion of the NDP, MAOA, MAOB, and the EFHC2 genes in a patient with Norrie disease, severe psychomotor retardation and myoclonic epilepsy","volume":"143A","author":"Rodriguez-Revenga","year":"2007","journal-title":"Am. J. Med. Genet. Part A"},{"key":"10.1016\/j.ejmg.2012.01.007_bib13","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/WNR.0b013e3282fd6e88","article-title":"Novel monoamine oxidase A knock out mice with human like spontaneous mutation","volume":"19","author":"Scott","year":"2008","journal-title":"Neuroreport"},{"key":"10.1016\/j.ejmg.2012.01.007_bib14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/ng1097-206","article-title":"Increased stress response and b-phenylethylamine in MAOB-deficient mice","volume":"17","author":"Grimbsy","year":"1997","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.ejmg.2012.01.007_bib15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/JCP.0b013e31820469ea","article-title":"Advances pertaining to the pharmacology and interactions of irreversible non-selective monoamine oxidase Inhibitors","volume":"31","author":"Gillman","year":"2011","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.ejmg.2012.01.007_bib16","series-title":"Catecholamines and Heart Disease","author":"Ganguly","year":"1991"},{"key":"10.1016\/j.ejmg.2012.01.007_bib17","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3949\/ccjm.77a.09103","article-title":"MAO inhibitors: risks, benefits, and lore","volume":"77","author":"Wimbiscus","year":"2010","journal-title":"Cleve Clin. J. Med."},{"key":"10.1016\/j.ejmg.2012.01.007_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0168-1605(99)00152-X","article-title":"Improved screening procedure for biogenic amine production by lactic acid bacteria","volume":"53","author":"Bover-Cid","year":"1999","journal-title":"Int. J. Food Microbiol."},{"key":"10.1016\/j.ejmg.2012.01.007_bib19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/bjc.1995.123","article-title":"Treatment with para-chlorophenylalanine antagonizes the emetic response and the serotonin-releasing actions of cisplatin in cancer patients","volume":"71","author":"Alfieri","year":"1995","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejmg.2012.01.007_bib20","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1046\/j.1471-4159.2000.0742067.x","article-title":"p-Ethynylphenylalanine: a potent inhibitor of tryptophan hydroxylase","volume":"74","author":"Stokes","year":"2000","journal-title":"J.\u00a0Neurochem."},{"issue":"4","key":"10.1016\/j.ejmg.2012.01.007_bib21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1023\/A:1014998926763","article-title":"Short- and long-term effects of p-ethynylphenylalanine on brain serotonin levels","volume":"27","author":"Zimmer","year":"2002","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejmg.2012.01.007_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jpeds.2008.07.045","article-title":"Clinical utility of array comparative genome hybridization: uncovering tumor susceptibility in individuals with developmental delay","volume":"154","author":"Adam","year":"2009","journal-title":"J.\u00a0Peadiatr"},{"issue":"5","key":"10.1016\/j.ejmg.2012.01.007_bib23","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/GIM.0b013e3181a028a5","article-title":"Impact of genotype-first diagnosis: the detection of microdeletion and microduplication syndromes with cancer predisposition by aCGH","volume":"11","author":"Adams","year":"2009","journal-title":"Genet. Med."}],"container-title":["European Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721212000092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721212000092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:39:43Z","timestamp":1761709183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769721212000092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S1769721212000092"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmg.2012.01.007","relation":{},"ISSN":["1769-7212"],"issn-type":[{"value":"1769-7212","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"De novo microdeletion of Xp11.3 exclusively encompassing the monoamine oxidase A and B genes in a male infant with episodic hypotonia: A genomics approach to personalized medicine","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmg.2012.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}